These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32294533)

  • 21. Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis.
    Bruns T; Nuraldeen R; Mai M; Stengel S; Zimmermann HW; Yagmur E; Trautwein C; Stallmach A; Strnad P
    Liver Int; 2017 Feb; 37(2):232-241. PubMed ID: 27473364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
    Moreau R; Jalan R; Gines P; Pavesi M; Angeli P; Cordoba J; Durand F; Gustot T; Saliba F; Domenicali M; Gerbes A; Wendon J; Alessandria C; Laleman W; Zeuzem S; Trebicka J; Bernardi M; Arroyo V;
    Gastroenterology; 2013 Jun; 144(7):1426-37, 1437.e1-9. PubMed ID: 23474284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio.
    Blasi A; Calvo A; Prado V; Reverter E; Reverter JC; Hernández-Tejero M; Aziz F; Amoros A; Cardenas A; Fernández J
    Hepatology; 2018 Dec; 68(6):2325-2337. PubMed ID: 29790188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.
    Horvatits T; Drolz A; Roedl K; Rutter K; Ferlitsch A; Fauler G; Trauner M; Fuhrmann V
    Liver Int; 2017 Feb; 37(2):224-231. PubMed ID: 27416294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
    Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
    Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing a cohort of Egyptian patients with acute-on-chronic liver failure.
    El Ray A; Fouad R; ElMakhzangy H; El Beshlawy M; Moreau R; Sherbiny M
    Eur J Gastroenterol Hepatol; 2021 Jul; 33(7):1023-1028. PubMed ID: 33905215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
    Clària J; Moreau R; Fenaille F; Amorós A; Junot C; Gronbaek H; Coenraad MJ; Pruvost A; Ghettas A; Chu-Van E; López-Vicario C; Oettl K; Caraceni P; Alessandria C; Trebicka J; Pavesi M; Deulofeu C; Albillos A; Gustot T; Welzel TM; Fernández J; Stauber RE; Saliba F; Butin N; Colsch B; Moreno C; Durand F; Nevens F; Bañares R; Benten D; Ginès P; Gerbes A; Jalan R; Angeli P; Bernardi M; Arroyo V;
    Hepatology; 2019 Apr; 69(4):1686-1701. PubMed ID: 30521097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
    Kerbert AJC; Gupta S; Alabsawy E; Dobler I; Lønsmann I; Hall A; Nielsen SH; Nielsen MJ; Gronbaek H; Amoros À; Yeung D; Macnaughtan J; Mookerjee RP; Macdonald S; Andreola F; Moreau R; Arroyo V; Angeli P; Leeming DJ; Treem W; Karsdal MA; Jalan R
    JHEP Rep; 2021 Dec; 3(6):100355. PubMed ID: 34805815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
    Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
    Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation.
    Schwarzkopf KM; Queck A; Thomas D; Angioni C; Cai C; Freygang Y; Rüschenbaum S; Geisslinger G; Zeuzem S; Welsch C; Lange CM
    PLoS One; 2019; 14(1):e0211537. PubMed ID: 30703151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure.
    Mehta G; Mookerjee RP; Sharma V; Jalan R
    Liver Int; 2015 Mar; 35(3):724-34. PubMed ID: 24703488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF.
    Blasi A; Patel VC; Adelmeijer J; Azarian S; Aziz F; Fernández J; Bernal W; Lisman T
    JHEP Rep; 2019 Sep; 1(3):179-187. PubMed ID: 32039368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute-on-chronic liver failure in cirrhosis.
    Arroyo V; Moreau R; Kamath PS; Jalan R; Ginès P; Nevens F; Fernández J; To U; García-Tsao G; Schnabl B
    Nat Rev Dis Primers; 2016 Jun; 2():16041. PubMed ID: 27277335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
    J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.
    Ruiz-Margáin A; Pohlmann A; Ryan P; Schierwagen R; Chi-Cervera LA; Jansen C; Mendez-Guerrero O; Flores-García NC; Lehmann J; Torre A; Macías-Rodríguez RU; Trebicka J
    Liver Transpl; 2018 May; 24(5):595-605. PubMed ID: 29476704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis.
    Wang SJ; Yin S; Gu WY; Zhang Y; Li H
    J Dig Dis; 2018 Oct; 19(10):614-625. PubMed ID: 30226019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality.
    Mücke MM; Rumyantseva T; Mücke VT; Schwarzkopf K; Joshi S; Kempf VAJ; Welsch C; Zeuzem S; Lange CM
    Liver Int; 2018 Apr; 38(4):645-653. PubMed ID: 28853199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of immunity in acutely decompensated cirrhosis and acute-on-chronic liver failure.
    Engelmann C; Zhang IW; Clària J
    Liver Int; 2023 Jun; ():. PubMed ID: 37365995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of non-thyroidal illness syndrome in acute decompensation of liver cirrhosis and acute-on-chronic liver failure.
    Langer MM; Bauschen A; Guckenbiehl S; Klauss S; Lutz T; Denk G; Zwanziger D; Moeller LC; Lange CM
    Front Endocrinol (Lausanne); 2023; 14():1104388. PubMed ID: 36755907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.